Specifically, ALDH3A1 enhances glycolysis to promote the cell proliferation of NSCLC by activating the HIF-1α/LDHA pathway, whereas this effect could be suppressed by β-elemene in vivo. The gene discussed is ALDH3A1; the disease is non-small cell lung carcinoma.